Emerging biomarkers in anaplastic oligodendroglioma: implications for clinical investigation and patient management.
about
Clinical management of grade III oligodendrogliomaBeyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification.Utilization and impact of adjuvant therapy in anaplastic oligodendroglioma: an analysis on 1692 patients.Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications.
P2860
Emerging biomarkers in anaplastic oligodendroglioma: implications for clinical investigation and patient management.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Emerging biomarkers in anaplas ...... gation and patient management.
@en
type
label
Emerging biomarkers in anaplas ...... gation and patient management.
@en
prefLabel
Emerging biomarkers in anaplas ...... gation and patient management.
@en
P2860
P356
P1433
P1476
Emerging biomarkers in anaplas ...... igation and patient management
@en
P2093
Solmaz Sahebjam
Warren P Mason
P2860
P304
P356
10.2217/CNS.13.26
P50
P577
2013-07-01T00:00:00Z